
France is Europe’s second-largest consumer of benzodiazepines – a class of sedatives that includes drugs like Valium and Xanax. Every year, nearly 10 million patients are prescribed these pills to treat anxiety and insomnia. While they are intended only for short-term use, treatments are often extended indefinitely, without proper supervision. Dependency sets in, affecting everyone from teenagers to elderly patients. FRANCE 24’s Olivia Bizot reports.
Trending
- US broadcaster CBS fires 60 Minutes’s Scott Pelley after clash with bosses | Media News
- US announces new tariffs over forced labour concerns
- Why Google wants to release millions of mosquitoes in the US
- Publishers in UK can opt out of Google AI search results
- O2 launches free new WhatsApp service to stop Brits from ‘doomscrolling’ led by Mel B
- Vreemd maar waar: vissen-dna helpt tegen rimpels
- Could lifting weights actually help you live longer?
- Battling a Deadly Ebola Outbreak in Eastern Congo
